Does response to induction chemotherapy (IC) predict locoregional control after concurrent chemoradiotherapy (CCRT) in locally advanced head and neck cancer (LAHNC)?

Oral Oncology

Volumn 50, Issue 6, 2014, Pages

  Cotter, Ryan ^a   Blacksburg, Seth ^a   Carpenter, Todd ^a   Kann, Benjamin ^a   Bakst, Richard ^a   Misiukiewicz, Krzysztof ^b   Posner, Marshall ^b   Som, Peter ^a   Gupta, Vishal ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Head and neck cancer; Induction chemotherapy; Locoregional control; Radiation therapy; Tumor volume

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL;

ADVANCED CANCER; CANCER RECURRENCE; CHEMORADIOTHERAPY; HEAD AND NECK CANCER; HEAD AND NECK CARCINOMA; HUMAN; INDUCTION CHEMOTHERAPY; LETTER; OVERALL SURVIVAL; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; TREATMENT FAILURE; TREATMENT RESPONSE; TUMOR VOLUME; DOSE RESPONSE; HEAD AND NECK NEOPLASMS; MULTIMODALITY CANCER THERAPY;

COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; HEAD AND NECK NEOPLASMS; HUMANS;

EID: 84900488930     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2014.03.002     Document Type: Letter

References (12)

1. M.R. Posner, D.M. Hershock, and C.R. Blajman et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer New Engl J Med 357 17 2007 1705 1715
2. P. Blanchard, J. Bourhis, and B. Lacas et al. Taxane-cisplatin- fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group J Clin Oncol: Official J Am Soc Clin Oncol 31 23 2013 2854 2860
3. Y. Pointreau, P. Garaud, and S. Chapet et al. Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation J Natl Cancer Inst 101 7 2009 498 506
4. A.D. Rapidis, M. Trichas, and E. Stavrinidis et al. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up Oral Oncol 42 7 Aug 2006 675 684
5. J.H. Lorch, O. Goloubeva, and R.I. Haddad et al. Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial Lancet Oncol 12 2 Feb 2011 153 159
6. H. Qin, J. Luo, Y.P. Zhu, H.L. Xie, W.Q. Yang, and W.B. Lei Combination of taxanes, Cisplatin and Fluorouracil as induction chemotherapy for locally advanced head and neck cancer: a meta-analysis PloS ONE 7 12 2012 e51526
7. A. Eisbruch, H.M. Kim, and F.Y. Feng et al. Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates Int J Radiat Oncol Biol Phys 81 3 2011 e93 e99
8. J.J. Caudell, O.L. Burnett 3rd, P.E. Schaner, J.A. Bonner, and J. Duan Comparison of methods to reduce dose to swallowing-related structures in head and neck cancer Int J Radiat Oncol Biol Phys 77 2 2010 462 467
9. D.I. Rosenthal, M.S. Chambers, and C.D. Fuller et al. Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer Int J Radiat Oncol Biol Phys 72 3 2008 747 755
10. D.L. Schwartz, A.S. Garden, and J. Thomas et al. Adaptive radiotherapy for head-and-neck cancer: initial clinical outcomes from a prospective trial Int J Radiat Oncol Biol Phys 83 3 2012 986 993
11. A. Eisbruch, H.M. Kim, J.E. Terrell, L.H. Marsh, L.A. Dawson, and J.A. Ship Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer Int J Radiat Oncol Biol Phys 50 3 2001 695 704
12. J.K. Salama, R.I. Haddad, and M.S. Kies et al. Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer Int J Radiat Oncol Biol Phys 75 3 2009 725 733